While the transthoracic needle biopsy (TTNB) was introduced for lung biopsy about 40 years ago, it is still mainstay of pathologic diagnosis in lung cancer, because it is relatively inexpensive and has the advantage of obtaining tissue regardless of tumorbronchus relationship. With several technological advances, clinicians can perform TTNB more safely and accurately. Utilizing ultrasound-guided biopsy for peripheral lesions contacting the pleura and rapid on-site evaluation during the procedure are expected to make up the weakness of TTNB. However, due to the inherent limitations of the percutaneous approach, the incidence of complications such as pneumothorax or bleeding are inevitably higher than those of other lung biopsy techniques. Selecting an appropriate guidance modality and optimal instruments could decrease the complication rate. Thorough understating and reflection of each biopsy modality with elaborate technique are fundamental for maximizing diagnostic accuracy and minimizing the complications.